2017 Fiscal Year Final Research Report
Establishment of novel strategy to treat rheumatoid arthritis by regulating intracellular zinc
Project/Area Number |
15K09521
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Collagenous pathology/Allergology
|
Research Institution | Chiba University |
Principal Investigator |
Ikeda Kei 千葉大学, 医学部附属病院, 講師 (10456014)
|
Co-Investigator(Kenkyū-buntansha) |
中島 裕史 千葉大学, 大学院医学研究院, 教授 (00322024)
須藤 明 千葉大学, 大学院医学研究院, 准教授 (50447306)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Keywords | 関節炎 / 亜鉛 / 軟骨 / ヘルパーT細胞 |
Outline of Final Research Achievements |
mRNA expressions of MTF-1 and MMP-3 were increased in the cartilage of ankle in mouse arthritis model (CIA). However, CIA did not exacerbate in cartilage-specific ZIP8 transgenic mice or cartilage-specific MT-1/2 knockout mice. On the other hand, no correlations were identified between mRNA expression of zinc transporters and intracellular zinc concentration in Th17 cells differentiated from mouse naive helper T cells. Furthermore, MT-1/2 knockdown did not affect helper T cell differentiation in vitro. These data indicate that zinc transporters are not likely to play significant roles in arthritis or helper T cell differentiation in mice.
|
Free Research Field |
リウマチ膠原病学・免疫学
|